82073129/National Natural Science Foundation of China[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2023	1
2024	2
2025	0

Page 1

Drug resistance in ovarian cancer: from mechanism to clinical trial.

Wang L, Wang X, Zhu X, Zhong L, Jiang Q, Wang Y, Tang Q, Li Q, Zhang C, Wang H, Zou D. Wang L, et al. Mol Cancer. 2024 Mar 28;23(1):66. doi: 10.1186/s12943-024-01967-3. Mol Cancer. 2024. PMID: 38539161 Free PMC article. Review.

Advances in ATM, ATR, WEE1, and CHK1/2 inhibitors in the treatment of PARP inhibitor-resistant ovarian cancer.

Tang Q, Wang X, Wang H, Zhong L, Zou D. Tang Q, et al. Cancer Biol Med. 2024 Feb 5;20(12):915-21. doi: 10.20892/j.issn.2095-3941.2023.0260. Cancer Biol Med. 2024. PMID: 38318945 Free PMC article. No abstract available.

Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103).

He M, Guo M, Zhou Q, Tang Y, Zhong L, Liu Q, Fan X, Zhao X, Zhang X, Chen G, Shen Y, Xu Q, Chen X, Li Y, Zou D. He M, et al. J Gynecol Oncol. 2023 May;34(3):e55. doi: 10.3802/jgo.2023.34.e55. Epub 2023 Mar 23. J Gynecol Oncol. 2023. PMID: 36998225 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year